Ten companies boasted strong double-digit gains week-on-week, despite a volatile trading observed toward the end of the week, as investors digested a flurry of strong corporate earnings and upbeat outlook, among others.

Of the said stocks, five notably climbed to new record highs.

In this article, we name the 10 top-performers of the week and break down the reasons behind their gains.

To come up with the list, we considered only the stocks with a market capitalization of $2 billion and 5 million shares in trading volume.

The stocks were chosen based on the percentage change in their prices on January 30 and February 6, 2026.

10. Super Micro Computer Inc. (NASDAQ:SMCI)

Super Micro grew its share prices by 18.10 percent week-on-week, primarily bolstered by its target of growing sales anew by more than double following stellar second-quarter results.

In an earnings call during the week, Super Micro Computer Inc. (NASDAQ:SMCI) said that its net income in the second quarter of fiscal year 2026 jumped by 25 percent to $400.56 million from $320.6 million in the same period a year earlier. Net sales soared by 123 percent to $12.68 billion from $5.68 billion.

For the six-month period, net income declined by 23.6 percent to $568.8 million from $744.9 million, while net sales jumped by 52 percent to $17.7 billion from $11.6 billion.

Super Micro Computer Inc. (NASDAQ:SMCI) attributed the results to its AI server and storage technology foundation, strong customer engagements, and expanding global manufacturing footprint.

Looking ahead, Super Micro Computer Inc. (NASDAQ:SMCI) is targeting to book $12.3 billion in net sales for the third quarter ending March 2026, which would imply a 167 percent growth from the $4.6 billion in the same quarter last year.

For the full fiscal year, net sales are projected to be at $40 billion, or an implied growth of 82 percent versus $21.97 billion in the full fiscal year 2025.

9. Corning Incorporated (NYSE:GLW)

Corning grew its share prices by 18.3 percent week-on-week to hit a new all-time high, as investors cheered its stellar earnings performance and new billion-dollar partnership with Meta Platforms Inc.

On Friday alone, the stock jumped to an all-time high of $122.56 before trimming a few cents to finish the session just up by 8.31 percent at $122.16 apiece.

Corning Incorporated (NYSE:GLW) announced earlier in the week that it more-than-tripled its net income to $1.596 billion from only $506 million in 2024, while net sales grew by 19 percent to $15.6 billion from $13.1 billion year-on-year.

In the fourth quarter alone, net income increased by 26 percent to $540 million from $310 million, while net sales inched up by 3 percent to $4.2 billion from $3.5 billion.

Encouraged by the results, Corning Incorporated (NYSE:GLW) raised its net sales growth outlook through 2028 to now be at $11 billion in incremental annualized sales, versus its previous guidance of $8 billion.

For this year alone, incremental annualized sales are targeted at $6.5 billion, up from its $6 billion outlook earlier.

The targets form part of what the company dubs as “Springboard plan”—a strategic multi-year initiative to drive growth between 2023 and 2028.

In other news, the company clinched a $6 billion partnership with Facebook operator Meta for the supply of fiber optic cables for its data centers.

The partnership is expected to generate 15 to 20 percent of new jobs under Corning Incorporated (NYSE:GLW).

8. Roivant Sciences Ltd. (NASDAQ:ROIV)

Roivant saw its share prices jump by 19.4 percent week-on-week, hitting a new all-time high, as investors snapped up shares following encouraging results from its pipeline projects, with one already seeking a new drug application (NDA) approval.

In Friday’s trading, the stock jumped to its highest price of $25.95 before trimming a few cents to finish the day just up by 22.14 percent at $25.82 apiece.

In an updated report, Roivant Sciences Ltd. (NASDAQ:ROIV) said that its unit, Priovant, saw strong results from its clinical trial of Brepocitinib in patients with cutaneous sarcoidosis (CS), having achieved a 22.3 percent improvement in CSAMI-A score—a measure of cutaneous sarcoidosis disease activity—after a 16-week therapy. This compares with a 0.7 percent improvement in the placebo group.

Meanwhile, Priovant has submitted an NDA with the Food and Drug Administration for the approval of brepocitinib to treat dermatomyositis.

A third clinical trial to check the efficacy of the therapy candidate for patients with non-infectious uveitis (NIU) is expected in the second half of calendar year 2026.

Meanwhile, Roivant Sciences Ltd. (NASDAQ:ROIV), through its other business units Immunovant and Pulmovant are underway with the clinical trials of other therapy candidates for the treatment of difficult-to-treat rheumatoid arthritis, Graves’ disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropath, Sjögren’s disease, and cutaneous lupus erythematosus, as well as pulmonary hypertension.

On Friday, Roivant Sciences Ltd. (NASDAQ:ROIV) also reported dismal earnings performance for the third quarter ending December 31, with the company swinging to a net loss attributable to shareholders of $265.89 million versus a $169 million attributable net income in the same period a year earlier.

The figure brought its attributable net loss in the nine-month period to $602.76 million, versus a $34.49 million attributable net income in the same period a year earlier.

7. Under Armour Inc. (NYSE:UAA)

Under Armour surged by 22.5 percent week-on-week, as investors took path from higher price targets from two investment companies, despite the sports apparel maker’s disappointing earnings performance in the third quarter of fiscal year 2026.

In separate market reports, Barclays and Truist Securities both raised their price targets for Under Armour Inc. (NYSE:UAA) to $8, from $6 and $5, respectively.

Barclays reaffirmed its “neutral” stance, while Truist maintained its“hold” recommendation for the stock.

Meanwhile, it received a “sell” recommendation from JPMorgan at a price target of $5.

The stock coverage followed Under Armour Inc.’s (NYSE:UAA) dismal earnings performance in the third quarter ending December 31, with the company swinging to a net loss of $430.8 million from a $1.2 million net income in the same period a year earlier.

Net revenues declined by 7 percent to $1.3 billion from $1.4 billion year-on-year.

For the nine-month period, Under Armour Inc. (NYSE:UAA) widened its net loss by 238 percent to $452 million from $133.8 million in the same period a year earlier. Net revenues dipped by 4.5 percent to $3.8 billion from $3.98 billion year-on-year.

6. Envista Holdings Corp. (NYSE:NVST)

Envista soared by 23.4 percent week-on-week to hit a nearly three-year high, as investors cheered its strong earnings performance, having swung to profitability last year.

On Friday alone, the dental equipment company soared to its highest price of $29.27 before paring gains to finish the session just up by 17.77 percent at $29.10 apiece.

In an updated report on Thursday, Envista Holdings Corp. (NYSE:NVST) said that it incurred a $47 million net income last year, reversing a $1.1 billion net loss in 2024.

Sales increased by 8 percent to $2.7 billion from $2.5 billion year-on-year.

In the fourth quarter alone, net profit soared by 2,642 percent to $32.9 million from only $1.2 million in the same period a year earlier. Sales also grew by 15 percent to $750.6 million from $652.9 million.

“With our disciplined focus on growth, operations, and people, Q4 2025 marked another quarter of continued progress for Envista…In the process, we posted positive growth in all major businesses and geographies, made broad-based improvements in employee development and engagement, and returned $166 million to shareholders through share repurchases,” Envista Holdings Corp. (NYSE:NVST) CEO Paul Keel.

For this year, Envista Holdings Corp. (NYSE:NVST) is looking to grow its core sales by 2 to 4 percent, while adjusted EBITDA is expected to increase by 7 to 13 percent.

Adjusted diluted earnings per share are pegged at $1.35 to $1.45.

5. Huntsman Corporation (NYSE:HUN)

Huntsman Corp. grew its share prices by 24.4 percent week-on-week, as investors loaded portfolios ahead of its earnings performance for the full-year and fourth quarter periods of 2025.

In a notice to its investors, Huntsman Corporation (NYSE:HUN) said that it would release its financial and operating highlights during market hours on Wednesday, February 18. An earnings call will be held to elaborate on the results.

For the fourth quarter period, Huntsman Corp. (NYSE:HUN) is targeting to hit the low end of its $25 million to $50 million adjusted EBITDA outlook following an unplanned outage at its Polyurethanes facility in Rotterdam, Netherlands during the period which negatively affected the larger of the two MDI lines.

Huntsman Corp. (NYSE:HUN) earlier said that the outage was expected to result in a $10 million negative impact on its fourth quarter adjusted EBITDA.

Huntsman Corp. (NYSE:HUN) is a global producer of differentiated and specialty chemicals such as polyurethanes, performance products, and adhesives. Its customers include BMW, GE, Chevron, Procter & Gamble, Unilever and Walkaroo, among others.

Last month, the company received higher price targets of $13 and $12 from investment firms RBC and UBS. However, the firms maintained “sector perform” and “neutral” ratings for the stock.

4. Teradyne Inc. (NASDAQ:TER)

Teradyne soared by 24.5 percent week-on-week to hit a new all-time high as investors took heart a strong earnings performance and 11 price target upgrades for its stock.

On Friday alone, Teradyne Inc. (NASDAQ:TER) climbed to its highest price of $301.38 before trimming gains to finish the session just up by 10.69 percent at $300.11 apiece.

Last week, the company reported a 2.2 percent jump in its full-year net income to $554 million versus $542 million in 2024. Net revenues increased by 13 percent to $3.2 billion from $2.82 billion year-on-year, amid strong earnings from semiconductor and product testing, as well as robotics.

In the fourth quarter alone, net income surged by 76 percent to $257 million from $146 million, while net revenues grew by 44 percent to $1.08 billion from $753 million.

“Our Q4 results were above the high end of our guidance range, fueled by AI-related demand in compute, networking and memory within our semi test business…In 2026, we expect year-over-year growth across all of our businesses, with strong momentum in compute driven by AI,” Teradyne Inc. (NASDAQ:TER) CEO Greg Smith said.

For the first quarter of the year, Teradyne Inc. (NASDAQ:TER) is targeting revenues between $1.15 billion and $1.25 billion.

Also last week, the company received price target upgrades from 11 investment firms, of which Susquehanna was the most bullish, raising its price target to $335 from $275 previously.

3. JetBlue Airways Corp. (NASDAQ:JBLU)

JetBlue saw its share prices jump by 30.59 percent week-on-week, primarily bolstered by lower losses last year, coupled with an upbeat growth outlook for full-year 2026.

In an updated report, JetBlue Airways Corp. (NASDAQ:JBLU) said that it narrowed its net loss last year by 24 percent to $602 million from $795 million in 2024, despite total operating revenues dipping by 2.3 percent to $9.06 billion from $9.3 billion year-on-year.

However, the company registered a 302 percent higher net loss of $177 million in the fourth quarter, versus $44 million in the same period a year earlier. Revenues dipped by 1.5 percent to $2.24 billion from $2.28 billion.

Additionally, the airline operator is confident to hit its incremental EBIT target of $850 million to $950 million in 2027, with $305 million already delivered last year, and another $310 million targeted this year.

For full-year 2026 alone, JetBlue Airways Corp. (NASDAQ:JBLU) is looking to grow its available seat miles (ASM) by 2.5 percent to 4.5 percent year-on-year, as well as its revenues per ASM by 2 to 5 percent.

“We saw strong underlying demand during the quarter and I’m very encouraged this momentum has carried forward into early 2026. Additionally, I am optimistic the constructive macroeconomic environment and industry capacity backdrop entering the year will support continued improvement,” JetBlue Airways Corp. (NASDAQ:JBLU) President Marty St. George said.

2. Enphase Energy Inc. (NASDAQ:ENPH)

Enphase Energy soared by 34.67 percent week-on-week, as investors loaded portfolios after the company reported a strong earnings performance last year.

In an updated report, Enphase Energy Inc. (NASDAQ:ENPH) said it was able to grow its net income last year by 68 percent to $172 million from $102.6 million, as revenues increased by 10.5 percent to $1.47 billion from $1.33 billion.

However, net income in the fourth quarter alone declined by 37.7 percent to $38.7 million from $62.16 million year-on-year. Net revenues decreased by 10.4 percent to $343 million from $382.7 million.

Looking ahead, Enphase Energy Inc. (NASDAQ:ENPH) is targeting to register revenues between $270 million and $300 million, which includes shipments of 100 to 120 MWh of IQ Batteries. This implies a decline of 16 percent to 24 percent from the $356.1 million in the first quarter of 2025.

Gross margin is expected to be within a range of 40 percent to 43 percent, including approximately five percentage points of reciprocal tariff impact.

In other developments, investment firm RBC Capital turned bullish for Enphase Energy Inc. (NASDAQ:ENPH), upgrading its stock rating to “outperform” from “sector perform” previously, as well as its price target to $54 from $31.

Wells Fargo, for its part, also issued an “outperform” rating for the stock, while raising its price target to $50 from $45 prior.

1. Lumentum Holdings Inc. (NASDAQ:LITE)

Lumentum Holdings skyrocketed by 40.87 percent week-on-week, to hit a new all-time high, as investors digested its swing to profitability in the second quarter of fiscal year 2026.

On Friday alone, the stock rallied to a fresh all-time high anew of $558.38 before trimming gains to finish the session just up by 9.43 percent at $551.99 apiece.

In an updated report, Lumentum Holdings Inc. (NASDAQ:LITE) said that it swung to a net profit of $78.2 million in the second quarter ending December from a $60.9 million loss in the same period a year earlier. Net revenues surged by 65 percent to $665.5 million from $402.2 million year-on-year.

Revenues hit the high-end of its earlier guidance, while profitability and earnings per share exceeded its previous outlook.

“Our forward guidance calls for over 85 percent year-over-year revenue growth, yet we are only at the starting line for two substantial opportunities: optical circuit switches (OCS) and co-packaged optics (CPO). In OCS, we are scaling rapidly to meet extraordinary customer demand that has already driven our backlog well beyond $400 million. In CPO, we received an incremental multi-hundred-million-dollar order, deliverable in first half of 2027. Our results continue to highlight the strength of our roadmaps for both optical components and systems, which make us mission-critical to the world’s AI leaders,” said Lumentum Holdings Inc. (NASDAQ:LITE) President and CEO Michael Hurlston.

Encouraged by the results, Lumentum Holdings Inc. (NASDAQ:LITE) raised its revenue growth outlook for the third quarter ending March to be at $780 million to $830 million, or an implied growth of 83 percent to 95 percent from the $425.2 million reported in the same quarter last year.

While we acknowledge the potential of LITE to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than LITE and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge fund investor letters by entering your email below.